The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Influenza Virus Triple Test Card Market Research Report 2025
Synopsis
The Influenza Virus Triple Test Card is a diagnostic tool used to detect influenza virus infection. It usually consists of a strip or card that is coated with specific antigens or antibodies. Using this test card can simultaneously detect influenza virus type A (including H1N1 and H3N2 subtypes) and influenza virus type B. When using the influenza virus triple test card, medical staff will take a patient's throat swab or nasal swab sample and drop the sample on a test strip or card. If antigens or antibodies to the flu virus are present in the sample, they will bind to the corresponding antibodies or antigens on the test strip or card, resulting in a visible line or color reaction. According to the line or color change on the test strip or card, medical personnel can judge whether the patient is infected with influenza virus, so as to take corresponding treatment measures in time.
Global Influenza Virus Triple Test Card market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Influenza Virus Triple Test Card market research.
Key manufacturers engaged in the Influenza Virus Triple Test Card industry include Shenzhen Microprofit Biotech Co. Ltd., Fisher Healthcare, Virax Biolabs, Abbott Laboratories, Roche, Quidel Corp., BioFire Diagnostics, Cepheid and Luminex Corp., etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Influenza Virus Triple Test Card were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Influenza Virus Triple Test Card market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Virus Triple Test Card market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Shenzhen Microprofit Biotech Co. Ltd.
Fisher Healthcare
Virax Biolabs
Abbott Laboratories
Roche
Quidel Corp.
BioFire Diagnostics
Cepheid
Luminex Corp.
GenMark Diagnostics
DiaSorin Molecular
Seegene Inc.
SD Biosensor
Access Bio Inc.
SolGent Co. Ltd.
Segment by Type
Fluorescent Immunoassay
Chromatographic Type
In Situ Hybridization
PCR Amplification Type
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Influenza Virus Triple Test Card report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
The Influenza Virus Triple Test Card is a diagnostic tool used to detect influenza virus infection. It usually consists of a strip or card that is coated with specific antigens or antibodies. Using this test card can simultaneously detect influenza virus type A (including H1N1 and H3N2 subtypes) and influenza virus type B. When using the influenza virus triple test card, medical staff will take a patient's throat swab or nasal swab sample and drop the sample on a test strip or card. If antigens or antibodies to the flu virus are present in the sample, they will bind to the corresponding antibodies or antigens on the test strip or card, resulting in a visible line or color reaction. According to the line or color change on the test strip or card, medical personnel can judge whether the patient is infected with influenza virus, so as to take corresponding treatment measures in time.
Global Influenza Virus Triple Test Card market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Influenza Virus Triple Test Card market research.
Key manufacturers engaged in the Influenza Virus Triple Test Card industry include Shenzhen Microprofit Biotech Co. Ltd., Fisher Healthcare, Virax Biolabs, Abbott Laboratories, Roche, Quidel Corp., BioFire Diagnostics, Cepheid and Luminex Corp., etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Influenza Virus Triple Test Card were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Influenza Virus Triple Test Card market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Virus Triple Test Card market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Shenzhen Microprofit Biotech Co. Ltd.
Fisher Healthcare
Virax Biolabs
Abbott Laboratories
Roche
Quidel Corp.
BioFire Diagnostics
Cepheid
Luminex Corp.
GenMark Diagnostics
DiaSorin Molecular
Seegene Inc.
SD Biosensor
Access Bio Inc.
SolGent Co. Ltd.
Segment by Type
Fluorescent Immunoassay
Chromatographic Type
In Situ Hybridization
PCR Amplification Type
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Influenza Virus Triple Test Card report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Influenza Virus Triple Test Card Market Overview
1.1 Product Overview and Scope of Influenza Virus Triple Test Card
1.2 Influenza Virus Triple Test Card Segment by Type
1.2.1 Global Influenza Virus Triple Test Card Market Value Comparison by Type (2023-2029)
1.2.2 Fluorescent Immunoassay
1.2.3 Chromatographic Type
1.2.4 In Situ Hybridization
1.2.5 PCR Amplification Type
1.3 Influenza Virus Triple Test Card Segment by Application
1.3.1 Global Influenza Virus Triple Test Card Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Influenza Virus Triple Test Card Market Size Estimates and Forecasts
1.4.1 Global Influenza Virus Triple Test Card Revenue 2018-2029
1.4.2 Global Influenza Virus Triple Test Card Sales 2018-2029
1.4.3 Global Influenza Virus Triple Test Card Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Influenza Virus Triple Test Card Market Competition by Manufacturers
2.1 Global Influenza Virus Triple Test Card Sales Market Share by Manufacturers (2018-2023)
2.2 Global Influenza Virus Triple Test Card Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Influenza Virus Triple Test Card Average Price by Manufacturers (2018-2023)
2.4 Global Influenza Virus Triple Test Card Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Influenza Virus Triple Test Card, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Influenza Virus Triple Test Card, Product Type & Application
2.7 Influenza Virus Triple Test Card Market Competitive Situation and Trends
2.7.1 Influenza Virus Triple Test Card Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Influenza Virus Triple Test Card Players Market Share by Revenue
2.7.3 Global Influenza Virus Triple Test Card Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Influenza Virus Triple Test Card Retrospective Market Scenario by Region
3.1 Global Influenza Virus Triple Test Card Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Influenza Virus Triple Test Card Global Influenza Virus Triple Test Card Sales by Region: 2018-2029
3.2.1 Global Influenza Virus Triple Test Card Sales by Region: 2018-2023
3.2.2 Global Influenza Virus Triple Test Card Sales by Region: 2024-2029
3.3 Global Influenza Virus Triple Test Card Global Influenza Virus Triple Test Card Revenue by Region: 2018-2029
3.3.1 Global Influenza Virus Triple Test Card Revenue by Region: 2018-2023
3.3.2 Global Influenza Virus Triple Test Card Revenue by Region: 2024-2029
3.4 North America Influenza Virus Triple Test Card Market Facts & Figures by Country
3.4.1 North America Influenza Virus Triple Test Card Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Influenza Virus Triple Test Card Sales by Country (2018-2029)
3.4.3 North America Influenza Virus Triple Test Card Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Influenza Virus Triple Test Card Market Facts & Figures by Country
3.5.1 Europe Influenza Virus Triple Test Card Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Influenza Virus Triple Test Card Sales by Country (2018-2029)
3.5.3 Europe Influenza Virus Triple Test Card Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Influenza Virus Triple Test Card Market Facts & Figures by Country
3.6.1 Asia Pacific Influenza Virus Triple Test Card Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Influenza Virus Triple Test Card Sales by Country (2018-2029)
3.6.3 Asia Pacific Influenza Virus Triple Test Card Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Influenza Virus Triple Test Card Market Facts & Figures by Country
3.7.1 Latin America Influenza Virus Triple Test Card Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Influenza Virus Triple Test Card Sales by Country (2018-2029)
3.7.3 Latin America Influenza Virus Triple Test Card Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Influenza Virus Triple Test Card Market Facts & Figures by Country
3.8.1 Middle East and Africa Influenza Virus Triple Test Card Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Influenza Virus Triple Test Card Sales by Country (2018-2029)
3.8.3 Middle East and Africa Influenza Virus Triple Test Card Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Influenza Virus Triple Test Card Sales by Type (2018-2029)
4.1.1 Global Influenza Virus Triple Test Card Sales by Type (2018-2023)
4.1.2 Global Influenza Virus Triple Test Card Sales by Type (2024-2029)
4.1.3 Global Influenza Virus Triple Test Card Sales Market Share by Type (2018-2029)
4.2 Global Influenza Virus Triple Test Card Revenue by Type (2018-2029)
4.2.1 Global Influenza Virus Triple Test Card Revenue by Type (2018-2023)
4.2.2 Global Influenza Virus Triple Test Card Revenue by Type (2024-2029)
4.2.3 Global Influenza Virus Triple Test Card Revenue Market Share by Type (2018-2029)
4.3 Global Influenza Virus Triple Test Card Price by Type (2018-2029)
5 Segment by Application
5.1 Global Influenza Virus Triple Test Card Sales by Application (2018-2029)
5.1.1 Global Influenza Virus Triple Test Card Sales by Application (2018-2023)
5.1.2 Global Influenza Virus Triple Test Card Sales by Application (2024-2029)
5.1.3 Global Influenza Virus Triple Test Card Sales Market Share by Application (2018-2029)
5.2 Global Influenza Virus Triple Test Card Revenue by Application (2018-2029)
5.2.1 Global Influenza Virus Triple Test Card Revenue by Application (2018-2023)
5.2.2 Global Influenza Virus Triple Test Card Revenue by Application (2024-2029)
5.2.3 Global Influenza Virus Triple Test Card Revenue Market Share by Application (2018-2029)
5.3 Global Influenza Virus Triple Test Card Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Shenzhen Microprofit Biotech Co. Ltd.
6.1.1 Shenzhen Microprofit Biotech Co. Ltd. Corporation Information
6.1.2 Shenzhen Microprofit Biotech Co. Ltd. Description and Business Overview
6.1.3 Shenzhen Microprofit Biotech Co. Ltd. Influenza Virus Triple Test Card Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Shenzhen Microprofit Biotech Co. Ltd. Influenza Virus Triple Test Card Product Portfolio
6.1.5 Shenzhen Microprofit Biotech Co. Ltd. Recent Developments/Updates
6.2 Fisher Healthcare
6.2.1 Fisher Healthcare Corporation Information
6.2.2 Fisher Healthcare Description and Business Overview
6.2.3 Fisher Healthcare Influenza Virus Triple Test Card Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Fisher Healthcare Influenza Virus Triple Test Card Product Portfolio
6.2.5 Fisher Healthcare Recent Developments/Updates
6.3 Virax Biolabs
6.3.1 Virax Biolabs Corporation Information
6.3.2 Virax Biolabs Description and Business Overview
6.3.3 Virax Biolabs Influenza Virus Triple Test Card Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Virax Biolabs Influenza Virus Triple Test Card Product Portfolio
6.3.5 Virax Biolabs Recent Developments/Updates
6.4 Abbott Laboratories
6.4.1 Abbott Laboratories Corporation Information
6.4.2 Abbott Laboratories Description and Business Overview
6.4.3 Abbott Laboratories Influenza Virus Triple Test Card Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Abbott Laboratories Influenza Virus Triple Test Card Product Portfolio
6.4.5 Abbott Laboratories Recent Developments/Updates
6.5 Roche
6.5.1 Roche Corporation Information
6.5.2 Roche Description and Business Overview
6.5.3 Roche Influenza Virus Triple Test Card Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Roche Influenza Virus Triple Test Card Product Portfolio
6.5.5 Roche Recent Developments/Updates
6.6 Quidel Corp.
6.6.1 Quidel Corp. Corporation Information
6.6.2 Quidel Corp. Description and Business Overview
6.6.3 Quidel Corp. Influenza Virus Triple Test Card Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Quidel Corp. Influenza Virus Triple Test Card Product Portfolio
6.6.5 Quidel Corp. Recent Developments/Updates
6.7 BioFire Diagnostics
6.6.1 BioFire Diagnostics Corporation Information
6.6.2 BioFire Diagnostics Description and Business Overview
6.6.3 BioFire Diagnostics Influenza Virus Triple Test Card Sales, Revenue and Gross Margin (2018-2023)
6.4.4 BioFire Diagnostics Influenza Virus Triple Test Card Product Portfolio
6.7.5 BioFire Diagnostics Recent Developments/Updates
6.8 Cepheid
6.8.1 Cepheid Corporation Information
6.8.2 Cepheid Description and Business Overview
6.8.3 Cepheid Influenza Virus Triple Test Card Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Cepheid Influenza Virus Triple Test Card Product Portfolio
6.8.5 Cepheid Recent Developments/Updates
6.9 Luminex Corp.
6.9.1 Luminex Corp. Corporation Information
6.9.2 Luminex Corp. Description and Business Overview
6.9.3 Luminex Corp. Influenza Virus Triple Test Card Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Luminex Corp. Influenza Virus Triple Test Card Product Portfolio
6.9.5 Luminex Corp. Recent Developments/Updates
6.10 GenMark Diagnostics
6.10.1 GenMark Diagnostics Corporation Information
6.10.2 GenMark Diagnostics Description and Business Overview
6.10.3 GenMark Diagnostics Influenza Virus Triple Test Card Sales, Revenue and Gross Margin (2018-2023)
6.10.4 GenMark Diagnostics Influenza Virus Triple Test Card Product Portfolio
6.10.5 GenMark Diagnostics Recent Developments/Updates
6.11 DiaSorin Molecular
6.11.1 DiaSorin Molecular Corporation Information
6.11.2 DiaSorin Molecular Influenza Virus Triple Test Card Description and Business Overview
6.11.3 DiaSorin Molecular Influenza Virus Triple Test Card Sales, Revenue and Gross Margin (2018-2023)
6.11.4 DiaSorin Molecular Influenza Virus Triple Test Card Product Portfolio
6.11.5 DiaSorin Molecular Recent Developments/Updates
6.12 Seegene Inc.
6.12.1 Seegene Inc. Corporation Information
6.12.2 Seegene Inc. Influenza Virus Triple Test Card Description and Business Overview
6.12.3 Seegene Inc. Influenza Virus Triple Test Card Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Seegene Inc. Influenza Virus Triple Test Card Product Portfolio
6.12.5 Seegene Inc. Recent Developments/Updates
6.13 SD Biosensor
6.13.1 SD Biosensor Corporation Information
6.13.2 SD Biosensor Influenza Virus Triple Test Card Description and Business Overview
6.13.3 SD Biosensor Influenza Virus Triple Test Card Sales, Revenue and Gross Margin (2018-2023)
6.13.4 SD Biosensor Influenza Virus Triple Test Card Product Portfolio
6.13.5 SD Biosensor Recent Developments/Updates
6.14 Access Bio Inc.
6.14.1 Access Bio Inc. Corporation Information
6.14.2 Access Bio Inc. Influenza Virus Triple Test Card Description and Business Overview
6.14.3 Access Bio Inc. Influenza Virus Triple Test Card Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Access Bio Inc. Influenza Virus Triple Test Card Product Portfolio
6.14.5 Access Bio Inc. Recent Developments/Updates
6.15 SolGent Co. Ltd.
6.15.1 SolGent Co. Ltd. Corporation Information
6.15.2 SolGent Co. Ltd. Influenza Virus Triple Test Card Description and Business Overview
6.15.3 SolGent Co. Ltd. Influenza Virus Triple Test Card Sales, Revenue and Gross Margin (2018-2023)
6.15.4 SolGent Co. Ltd. Influenza Virus Triple Test Card Product Portfolio
6.15.5 SolGent Co. Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Influenza Virus Triple Test Card Industry Chain Analysis
7.2 Influenza Virus Triple Test Card Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Influenza Virus Triple Test Card Production Mode & Process
7.4 Influenza Virus Triple Test Card Sales and Marketing
7.4.1 Influenza Virus Triple Test Card Sales Channels
7.4.2 Influenza Virus Triple Test Card Distributors
7.5 Influenza Virus Triple Test Card Customers
8 Influenza Virus Triple Test Card Market Dynamics
8.1 Influenza Virus Triple Test Card Industry Trends
8.2 Influenza Virus Triple Test Card Market Drivers
8.3 Influenza Virus Triple Test Card Market Challenges
8.4 Influenza Virus Triple Test Card Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
